Company History

  • January 2018

    China Biologic acquired 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co., Ltd. from PW Medtech Group Limited.
  • December 2017

    Shandong Taibang received the operating permit for the newly-built plasma collection station in Ju County of Rizhao City, Shandong Province.
  • October 2017

    Shandong Taibang received manufacturing approval certificate for Human Fibrinogen (“Fibrinogen”) from China Food and Drug Administration (“CFDA”).
  • July 2017

    China Biologic completed the redomicile merger to reorganize itself as a Cayman Islands company and changed its name from China Biologic Products, Inc. to China Biologic Products Holdings, Inc.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:2 [1] [2] [3] [4] [5] [6] [7] [8] [9] ...
© 2018 China Biologic Products Holdings, Inc. All Rights Reserved.           京ICP备18053264号